Robin Tuytten serves as Vice President Research and Development of Metabolomic Diagnostics and its subsidiary company Inform Biosciences. Robin holds PhD in Chemistry and has been involved in biomarker discovery and development for nearly a decade. Robin has been leading preeclampsia biomarker discovery programs in several start-up companies, and is a co-inventor on several preeclampsia biomarker patent applications.